Five papers extend the list of cancers that respond to therapies that restore antitumour immunity by blocking the PD-1 pathway, and characterize those patients who respond best. See Letters p.558, p.563, p.568, p.572 & p.577
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells
BMC Nutrition Open Access 04 March 2024
-
A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
BMC Cancer Open Access 23 June 2022
-
The Adaptive and Innate Immune Cell Landscape of Uterine Leiomyosarcomas
Scientific Reports Open Access 20 January 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Coley, W. B. Proc. R. Soc. Med. 3, 1–48 (1910).
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Nature Immunol. 3, 991–998 (2002).
Koebel, C. M. et al. Nature 450, 903–907 (2007).
Shankaran, V. et al. Nature 410, 1107–1111 (2001).
Powles, T. et al. Nature 515, 558–562 (2014).
Herbst, R. S. et al. Nature 515, 563–567 (2014).
Tumeh, P. C. et al. Nature 515, 568–571 (2014).
Yadav, M. et al. Nature 515, 572–576 (2014).
Gubin, M. M. et al. Nature 515, 577–581 (2014).
Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P. & Wolchok, J. D. Annu. Rev. Med. 65, 185–202 (2014).
Robert, C. et al. Lancet 384, 1109–1117 (2014).
Topalian, S. L. et al. J. Clin. Oncol. 32, 1020–1030 (2014).
Wolchok, J. D. et al. Ann. Oncol. 24, 2174–2180 (2013).
Brahmer, J. R. et al. N. Engl. J. Med. 366, 2455–2465 (2012).
Topalian, S. L. et al. N. Engl. J. Med. 366, 2443–2454 (2012).
Hamid, O. et al. N. Engl. J. Med. 369, 134–144 (2013).
Taube, J. M. et al. Sci. Transl. Med. 4, 127ra37 (2012).
Brahmer, J. R. et al. J. Clin. Oncol. 28, 3167–3175 (2010).
Matsushita, H. et al. Nature 482, 400–404 (2012).
Duan, F. et al. J. Exp. Med. 211, 2231–2248 (2014).
Snyder, A. et al. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1406498 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wolchok, J., Chan, T. Antitumour immunity gets a boost. Nature 515, 496–498 (2014). https://doi.org/10.1038/515496a
Published:
Issue Date:
DOI: https://doi.org/10.1038/515496a
This article is cited by
-
Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells
BMC Nutrition (2024)
-
A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
BMC Cancer (2022)
-
Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
Nature Cancer (2021)
-
The Adaptive and Innate Immune Cell Landscape of Uterine Leiomyosarcomas
Scientific Reports (2020)
-
The hypoxic tumour microenvironment
Oncogenesis (2018)